STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #750 by analyst upside · 2026-08-08
KARD
Kardigan, Inc.
Healthcare · Market Cap $2B · P/E 0x
ANALYST PRICE TARGET
+112.2%
implied upside to consensus target
Current Price $20.5
Consensus Target $43.5
Bull Target $51.0
Bear Target $37.0
Analysts Covering 4
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
3
Hold
0
Sell
0
52-Week Low $16.25
52-Week High $27.0
YTD Return -6.8%
FUNDAMENTALS
Market Cap $2B
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-2.58
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) N/A
Profit Margin N/A
52-WEEK RANGE
52-Week Low $16.25
52-Week High $27.0
Current Price $20.5
Bear Target $37.0
Bull Target $51.0
● Now $20.5 ● Target $43.5
TRADING DATA
Avg Volume 602K
YTD Return -6.8%
Analyst Count 4
Consensus Buy
Upside to Target +112.2%
Last Updated 2026-08-08

ANALYST SUMMARY

Kardigan, Inc. (KARD) is currently trading at $20.5 with a Wall Street consensus price target of $43.5, implying potential upside of 112.2% over the next 12 months. 4 analysts currently cover KARD, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $51.0, while the most cautious has a target of $37.0.

KARD operates in the Healthcare sector with a market capitalisation of $2B. The stock is down 6.8% year-to-date and is currently trading near the lower end of its 52-week range of $16.25 – $27.0.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
55
out of 100
Coverage depth
12/30
Consensus clarity
16/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →